![](/img/cover-not-exists.png)
B22Radium-223 in metastatic castration-resistant prostate cancer (mCRPC): efficacy and safety in real-life experience
Rebuzzi, S E, Prelaj, A, Pozzi, C, Ferrara, C, Frantellizzi, V, Follacchio, G A, de Vincentis, G, Tomao, S, Bianco, VVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx423.021
Date:
October, 2017
File:
PDF, 62 KB
english, 2017